THC — Tenet Healthcare Income Statement
0.000.00%
- $11.52bn
- $26.05bn
- $20.67bn
- 85
- 87
- 79
- 97
Annual income statement for Tenet Healthcare, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 17,640 | 19,485 | 19,174 | 20,548 | 20,665 |
Cost of Revenue | |||||
Gross Profit | 14,658 | 16,157 | 15,901 | 16,958 | 17,018 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 15,967 | 16,688 | 16,950 | 18,049 | 14,717 |
Operating Profit | 1,673 | 2,797 | 2,224 | 2,499 | 5,948 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 671 | 1,888 | 1,344 | 1,617 | 5,248 |
Provision for Income Taxes | |||||
Net Income After Taxes | 768 | 1,477 | 1,000 | 1,311 | 4,064 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 399 | 914 | 411 | 611 | 3,200 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 399 | 914 | 411 | 611 | 3,201 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.25 | 5.83 | 5.59 | 9.89 | 13.1 |